Dr. Agarwal's Eye [DRAGARWQ] vs Max Healthcare [MAXHEALTH] Detailed Stock Comparison

Dr. Agarwal's Eye Hospital Ltd.

BSE
Loading...

Max Healthcare Institute Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dr. Agarwal's Eye Hospital Ltd. wins in 12 metrics, Max Healthcare Institute Ltd. wins in 8 metrics, with 0 ties. Dr. Agarwal's Eye Hospital Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dr. Agarwal's Eye Hospital Ltd. Max Healthcare Institute Ltd. Better
P/E Ratio (TTM) 34.01 68.81 Dr. Agarwal's Eye Hospital Ltd.
Price-to-Book Ratio 7.52 9.77 Dr. Agarwal's Eye Hospital Ltd.
Debt-to-Equity Ratio 106.45 32.58 Max Healthcare Institute Ltd.
PEG Ratio 1.81 2.65 Dr. Agarwal's Eye Hospital Ltd.
EV/EBITDA 20.64 46.94 Dr. Agarwal's Eye Hospital Ltd.
Profit Margin (TTM) 15.50% 17.43% Max Healthcare Institute Ltd.
Operating Margin (TTM) 19.54% 20.66% Max Healthcare Institute Ltd.
EBITDA Margin (TTM) 19.54% 20.66% Max Healthcare Institute Ltd.
Return on Equity 26.07% 11.47% Dr. Agarwal's Eye Hospital Ltd.
Return on Assets (TTM) 8.91% 7.07% Dr. Agarwal's Eye Hospital Ltd.
Free Cash Flow (TTM) $-83.80M $4.94B Max Healthcare Institute Ltd.
Dividend Yield 0.11% 0.23% Max Healthcare Institute Ltd.
1-Year Return 12.35% -17.87% Dr. Agarwal's Eye Hospital Ltd.
Price-to-Sales Ratio (TTM) 5.39 11.99 Dr. Agarwal's Eye Hospital Ltd.
Enterprise Value $26.69B $1,003.68B Max Healthcare Institute Ltd.
EV/Revenue Ratio 5.92 12.33 Dr. Agarwal's Eye Hospital Ltd.
Gross Profit Margin (TTM) 78.09% 78.70% Max Healthcare Institute Ltd.
Revenue per Share (TTM) $952 $84 Dr. Agarwal's Eye Hospital Ltd.
Earnings per Share (Diluted) $147.68 $14.58 Dr. Agarwal's Eye Hospital Ltd.
Beta (Stock Volatility) -0.57 0.15 Dr. Agarwal's Eye Hospital Ltd.

Dr. Agarwal's Eye Hospital Ltd. vs Max Healthcare Institute Ltd. Stock Performance Analysis

Loading Price Chart...

DRAGARWQ
MAXHEALTH

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dr. Agarwal's Eye Hospital Ltd.0.58%0.12%-1.62%6.94%-8.52%-6.31%
Max Healthcare Institute Ltd.1.62%2.13%-2.02%6.01%-5.21%-1.95%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dr. Agarwal's Eye Hospital Ltd.12.35%240.02%1,131.89%2,480.68%5,282.48%17,498.05%
Max Healthcare Institute Ltd.-17.87%70.33%304.25%806.00%806.00%806.00%

Performance & Financial Health Analysis: Dr. Agarwal's Eye Hospital Ltd. vs Max Healthcare Institute Ltd.

MetricDRAGARWQMAXHEALTH
Market Information
Market Cap i₹24.28B₹979.76B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,2562,314,725
90 Day Avg. Volume i1,3782,882,172
Last Close₹4,991.20₹1,028.90
52 Week Range₹4,142.00 - ₹6,392.00₹903.00 - ₹1,314.30
% from 52W High-21.91%-21.71%
All-Time High₹7,300.00 (Dec 30, 2024)₹1,314.30 (Jul 04, 2025)
% from All-Time High-31.63%-21.71%
Growth Metrics
Quarterly Revenue Growth0.22%0.11%
Quarterly Earnings Growth0.66%0.26%
Financial Health
Profit Margin (TTM) i0.16%0.17%
Operating Margin (TTM) i0.20%0.21%
Return on Equity (TTM) i0.26%0.11%
Debt to Equity (MRQ) i106.4532.58
Cash & Liquidity
Book Value per Share (MRQ)₹668.22₹102.71
Cash per Share (MRQ)₹191.98₹5.12
Operating Cash Flow (TTM) i₹738.70M₹13.02B
Levered Free Cash Flow (TTM) i₹546.50M₹10.76B
Dividends
Last 12-Month Dividend Yield i0.11%0.23%
Last 12-Month Dividend i₹5.00₹3.00

Valuation & Enterprise Metrics Analysis: Dr. Agarwal's Eye Hospital Ltd. vs Max Healthcare Institute Ltd.

MetricDRAGARWQ (Apr 26, 2026)MAXHEALTH (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i34.0168.81
Forward P/E i516.7747.64
PEG Ratio i1.812.65
Price to Sales (TTM) i5.3911.99
Price to Book (MRQ) i7.529.77
Market Capitalization
Market Capitalization i₹24.28B₹979.76B
Enterprise Value i₹26.69B₹1.00T
Enterprise Value Metrics
Enterprise to Revenue i5.9212.33
Enterprise to EBITDA i20.6446.94
Risk & Other Metrics
Beta i-0.570.15
Book Value per Share (MRQ) i₹668.22₹102.71

Financial Statements Comparison: Dr. Agarwal's Eye Hospital Ltd. vs Max Healthcare Institute Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDRAGARWQ (2025)MAXHEALTH (2025)
Revenue/Sales i3.94B69.10B
Cost of Goods Sold i896.20M14.77B
COGS % of Revenue i22.8%21.4%
Gross Profit i3.04B54.33B
Gross Margin i77.2%78.6%
Research & Development iN/AN/A
Operating Income (EBIT) i813.30M15.76B
Operating Margin i20.6%22.8%
EBITDA i1.22B20.49B
EBITDA Margin i31.1%29.7%
Pre-Tax Income i707.00M14.06B
Pre-Tax Income % of Revenue i17.9%20.4%
Income Tax i160.50M3.30B
Income Tax % of Revenue i4.1%4.8%
Net Income (Profit) i546.50M10.76B
Profit Margin i13.9%15.6%

Balance Sheet & Liquidity Metrics

MetricDRAGARWQ (2025)MAXHEALTH (2025)
Cash & Equivalents i111.60M6.62B
Total Current Assets i559.40M15.93B
Total Current Assets % of Revenue i14.2%23.0%
Total Current Liabilities i869.80M18.14B
Total Current Liabilities % of Revenue i22.1%26.2%
Long-Term Debt i3.06B27.68B
Long-Term Debt % of Revenue i77.6%40.1%
Total Shareholders Equity i2.10B93.81B
Retained Earnings i1.99B31.11B
Retained Earnings % of Revenue i50.4%45.0%
Property, Plant & Equipment i1.37B19.32B

Cash Flow Statement Comparison

MetricDRAGARWQ (2025)MAXHEALTH (2025)
Operating Cash Flow i738.70M13.02B
Operating Cash Flow % of Revenue i18.8%18.8%
Capital Expenditures i4.10M-9.59B
Free Cash Flow i-83.80M4.94B
FCF Margin i-2.1%7.1%
Debt Repayment i-111.30M-10.54B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDRAGARWQMAXHEALTH
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i4.83M973.19M
Float Shares i1.08M697.18M
% Held by Insiders i77.59%26.51%
% Held by Institutions i3.57%54.33%
% Held by Public i18.84%19.16%

Dividend Analysis & Yield Comparison: Dr. Agarwal's Eye Hospital Ltd. vs Max Healthcare Institute Ltd.

MetricDRAGARWQMAXHEALTH
Last 12-Month Dividend i₹5.00₹3.00
Last 12-Month Dividend Yield i0.11%0.23%
3-Year Avg Annual Dividend i₹4.50₹1.33
3-Year Avg Dividend Yield i0.12%0.15%
3-Year Total Dividends i₹13.50₹4.00
Ex-Dividend DateNov 08, 2024Jul 04, 2025